Brentwood Capital Advisors

Brentwood Capital Advisors (BCA) is an independent investment bank specializing in mergers and acquisitions, recapitalizations, corporate divestitures, and growth capital advisory for middle market companies. Founded in 1999, the firm focuses primarily on healthcare services, healthcare technology, business services, and family-owned companies. The firm reports completing over 250 transactions with a combined value exceeding $40 billion.

BCA's healthcare practice spans multiple verticals including revenue cycle management, behavioral health treatment, home health and hospice, infusion therapy, autism services, and medical transport. The firm's approach emphasizes senior-level involvement throughout engagements, offering what they describe as candid, solution-agnostic advice tailored to each client's specific situation rather than standardized recommendations.

Recent transactions demonstrate activity across both buy-side and sell-side mandates, with deals involving private equity recapitalizations, strategic acquisitions, and growth investments. The firm's average partner experience exceeds 30 years in investment banking, suggesting depth in middle market transaction execution.

Consider BCA when seeking experienced M&A advisory for a healthcare services or healthcare technology business generating sufficient scale for middle market private equity or strategic interest. The firm's extensive transaction history across healthcare verticals suggests familiarity with sector-specific valuation drivers, buyer landscapes, and deal structures.

Engagements appear to involve comprehensive transaction support from initial strategic evaluation through closing, with emphasis on identifying buyers or investors aligned with client priorities beyond just valuation. Client testimonials highlight the firm's responsiveness and guidance through complex transaction processes.

Healthcare represents the primary focus of BCA's practice, with specific expertise in healthcare services (behavioral health, home health, hospice, infusion therapy, autism services, addiction treatment) and healthcare technology (revenue cycle management, contract lifecycle management, practice management software). The firm's transaction portfolio demonstrates consistent activity across both provider-focused and healthcare IT segments.

Recent deals span the continuum from acute care revenue cycle optimization to post-acute care delivery models and specialty behavioral health treatment, suggesting familiarity with diverse healthcare reimbursement models, regulatory considerations, and buyer ecosystems across healthcare subsectors.

The ideal client is a profitable, growth-oriented healthcare services or healthcare technology company with revenue typically ranging from $10 million to $200 million, seeking a sale, recapitalization, or growth capital. Companies may be family-owned businesses pursuing first-time transactions, founder-owned enterprises evaluating exit options, or private equity-backed platforms executing add-on acquisition strategies in fragmented healthcare verticals.